Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Calaspargase pegol by Les Laboratoires Servier for Metastatic Pancreatic Cancer: Likelihood of Approval
Calaspargase pegol is under clinical development by Les Laboratoires Servier and currently in Phase I for Metastatic Pancreatic Cancer. According...
S-65487 by Les Laboratoires Servier for Refractory Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Refractory Chronic Lymphocytic Leukemia (CLL)....
S-65487 by Les Laboratoires Servier for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Relapsed Chronic Lymphocytic Leukemia (CLL)....
S-65487 by Les Laboratoires Servier for Marginal Zone B-cell Lymphoma: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Marginal Zone B-cell Lymphoma. According...
S-65487 by Les Laboratoires Servier for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Relapsed Acute Myeloid Leukemia. According...
S-65487 by Les Laboratoires Servier for Refractory Acute Myeloid Leukemia: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Refractory Acute Myeloid Leukemia. According...
S-65487 by Les Laboratoires Servier for Refractory Multiple Myeloma: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Refractory Multiple Myeloma. According to...
S-65487 by Les Laboratoires Servier for Follicular Lymphoma: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Follicular Lymphoma. According to GlobalData,...
S-65487 by Les Laboratoires Servier for Mantle Cell Lymphoma: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Mantle Cell Lymphoma. According to...
S-65487 by Les Laboratoires Servier for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Diffuse Large B-Cell Lymphoma. According...
Sym-023 by Les Laboratoires Servier for Lymphoma: Likelihood of Approval
Sym-023 is under clinical development by Les Laboratoires Servier and currently in Phase I for Lymphoma. According to GlobalData, Phase...
Vorasidenib citrate by Les Laboratoires Servier for Low-Grade Glioma: Likelihood of Approval
Vorasidenib citrate is under clinical development by Les Laboratoires Servier and currently in Pre-Registration for Low-Grade Glioma. According to GlobalData,...
Vorasidenib citrate by Les Laboratoires Servier for Oligodendroglioma: Likelihood of Approval
Vorasidenib citrate is under clinical development by Les Laboratoires Servier and currently in Pre-Registration for Oligodendroglioma. According to GlobalData, Pre-Registration...
Vorasidenib citrate by Les Laboratoires Servier for Astrocytoma: Likelihood of Approval
Vorasidenib citrate is under clinical development by Les Laboratoires Servier and currently in Pre-Registration for Astrocytoma. According to GlobalData, Pre-Registration...
Ivosidenib by Les Laboratoires Servier for Low-Grade Glioma: Likelihood of Approval
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase I for Low-Grade Glioma. According to GlobalData,...
Ivosidenib by Les Laboratoires Servier for Chondrosarcoma: Likelihood of Approval
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase II for Chondrosarcoma. According to GlobalData, Phase...
S-65487 by Les Laboratoires Servier for Non-Hodgkin Lymphoma: Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData,...
Sym-021 by Les Laboratoires Servier for Lymphoma: Likelihood of Approval
Sym-021 is under clinical development by Les Laboratoires Servier and currently in Phase I for Lymphoma. According to GlobalData, Phase...
S-65487 by Les Laboratoires Servier for Multiple Myeloma (Kahler Disease): Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase I for Multiple Myeloma (Kahler Disease). According...
S-65487 by Les Laboratoires Servier for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
S-65487 is under clinical development by Les Laboratoires Servier and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute...